Cargando…
Rat bone marrow mesenchymal stem cells (BMSCs) inhibit liver fibrosis by activating GSK3β and inhibiting the Wnt3a/β-catenin pathway
BACKGROUND: Bone marrow mesenchymal stem cells (BMSCs) can effectively alleviate liver fibrosis, which is a pathological injury caused by various chronic liver diseases. This study aimed to investigate the antifibrotic effects of BMSCs and elucidate the underlying mechanism by which BMSCs affect liv...
Autores principales: | Liu, Zhaoguo, Zhou, Song, Zhang, Ya, Zhao, Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017036/ https://www.ncbi.nlm.nih.gov/pubmed/35440002 http://dx.doi.org/10.1186/s13027-022-00432-4 |
Ejemplares similares
-
Ginsenoside Rg1 Improves Differentiation by Inhibiting Senescence of Human Bone Marrow Mesenchymal Stem Cell via GSK-3β and β-Catenin
por: Wang, Ziling, et al.
Publicado: (2020) -
TGF-β1 enhanced myocardial differentiation through inhibition of the Wnt/β-catenin pathway with rat BMSCs
por: Lv, Yang, et al.
Publicado: (2020) -
Direct Inhibition of GSK3β by the Phosphorylated Cytoplasmic Domain of LRP6 in Wnt/β-Catenin Signaling
por: Piao, Shunfu, et al.
Publicado: (2008) -
Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3–independent β-catenin degradation
por: Topol, Lilia, et al.
Publicado: (2003) -
TIMP-1 inhibits proliferation and osteogenic differentiation of hBMSCs through Wnt/β-catenin signaling
por: Liang, Tangzhao, et al.
Publicado: (2019)